Completed OBSERVATIONAL NCT05252559

Ultrafiltration on Coagulation Performance in Cardiac Surgery

Effect of Modified Ultrafiltration on Whole Blood Coagulation in Cardiac Surgery With Cardiopulmonary Bypass: Retrospective Analysis

Sponsor: Konkuk University Medical Center

Conditions Cardiac Valve Disease

Interventions maximal clot firmness in EXTEM assay of ROTEM test ultrafiltration

Updated 5 times since 2022 Last updated: Jun 8, 2022 Started: Aug 1, 2021 Primary completion: May 1, 2022 Completion: Jun 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cardiac Valve Disease and is currently completed. Konkuk University Medical Center leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jul 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Mar 2022 — Jul 2022 [monthly]

Recruiting

First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Konkuk University Medical Center

Data source: Konkuk University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea